B lymphocytes contribute to autoimmune disease pathogenesis: current trends and clinical implications (Q35172012)

6 August 2017

1 reference

title

B lymphocytes contribute to autoimmune disease pathogenesis: current trends and clinical implications (English)

1 reference

6 August 2017

1 reference

1 reference

Joseph M Tuscano

1

1 reference

PubMed ID

12848966

6 August 2017

Geoffrey S Harris

series ordinal

2

1 reference

PubMed ID

12848966

6 August 2017

Thomas F Tedder

series ordinal

3

1 reference

6 August 2017

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

2

1 reference

6 August 2017

2

1 reference

6 August 2017

101-108

1 reference

The central and multiple roles of B cells in lupus pathogenesis

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Transitional B cells are the target of negative selection in the B cell compartment

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

BAFF: a fundamental survival factor for B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

The role of BAFF in B-cell maturation, T-cell activation and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

B cell development: signal transduction by antigen receptors and their surrogates.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Introduction: response-regulators of B lymphocyte signaling thresholds provide a context for antigen receptor signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Regulation of B-cell signal transduction by adaptor proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

A critical role for complement in maintenance of self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

An open study of B lymphocyte depletion in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900148-9

7 January 2021

10.1016/S1568-9972(02)00148-9

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12848966